COVID-19 Booster and IIV Schedule in Immunocompromised Hosts

Clinical trial NCT06599658 · RECRUITING

Trial details

NCT number: NCT06599658
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

COVID 19 Influenza Rheumatoid Arthritis (RA)Systemic Lupus Erthematosus Inflammatory Bowel Disease Solid Organ Transplant Recipients Immunocompromised Host People Living With HIV

Start date: 2024-11-20
Primary completion: 2027-03-31
Enrollment: 660

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.